Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Publication date: May 2021Source: The Lancet Haematology, Volume 8, Issue 5Author(s): Bart J Biemond, Anil Tombak, Yurdanur Kilinc, Murtadha Al-Khabori, Miguel Abboud, Mohammed Nafea, Adlette Inati, Yasser Wali, Jens Kristensen, Jan Kowalski, Ellen Donnelly, John Ohd, Erfan Nur, Anita W. Rijneveld, Alibülent Antmen, Marvin Reid, Gabriel Ukala, Lisa Kirven-Dawes, Curis Yeates, Hugh Wong
Source: The Lancet Haematology - Category: Hematology Source Type: research